Altria: It's Time To Return To This High Dividend Yield Opportunity (Rating Upgrade)
Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...
STAT3d
FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...
US regulators propose capping nicotine in cigarettes at non-addictive levels
U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first ...
FDA Wants to Curb Nicotine in Cigarettes, But Plan’s Fate Rests With Trump
Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming ...
World’s Largest Tobacco Company Continues Silent Entry Into Cannabis: Is Philip Morris A Medical Marijuana Supporter?
Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...
Altria Group, Inc. (NYSE:MO) Receives Average Recommendation of “Hold” from Brokerages
Shares of Altria Group, Inc. (NYSE:MO – Get Free Report) have received an average recommendation of “Hold” from the eight ...
FDA approves Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
The war on smoking turns to cigarettes with ultralow nicotine
The Biden White House is expected to formally propose a plan ordering cigarette nicotine levels to be reduced dramatically.